NCDs & influenza infographic
About IFPMA
IFPMA represents the innovative pharmaceutical industry at the international level, engaging in official relations with the United Nations and multilateral organizations. Our vision is to ensure that scientific progress translates into the next generation of medicines and vaccines that deliver a healthier future for people everywhere.
ifpma.org
To achieve this, we act as a trusted partner, bringing our members' expertise to champion pharmaceutical innovation, drive policy that supports the research, development, and delivery of health technologies, and create sustainable solutions that advance global health.
Related news and resources
Investing in productive economies and resilient societies: The vital role of adult immunization
As populations age and rates of NCDs rise across all demographics, adult immunization represents a high-impact and cost-effective investment in economic growth and societal resilience. This two-pager outlines four policy recommendations to ensure adult immunization is prioritized within national budgets.
Read more
79th World Health Assembly (WHA79): Follow-up to the political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases
On 21 May 2026, IFPMA published a statement on the follow-up to the political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases, on the margins of the World Health Assembly. IFPMA welcomes WHO’s continued efforts to tackle one of the greatest health challenges of our lifetimes....
Read moreFinancing health systems: Leveraging the benefits of investing in prevention against NCDs
Investing in the prevention and treatment of non-communicable diseases (NCDs) can strengthen health systems, protect economic productivity, and improve population wellbeing. Evidence shows that every dollar invested in preventing and managing NCDs generates substantial returns through reduced healthcare costs, improved workforce participation, and healthier, more resilient societies. Yet despite this compelling investment case, progress remains...
Read more